Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback